WHY NOVUS CAPITAL?

is an investment and financial services company specialising in Investment Banking, Corporate Advisory and Share Trading services for Australian corporate and private clients, and overseas corporate clients.

CONTACT INFO
  • Address: Level 24, Royal Exchange Building, 56 Pitt Street, Sydney, NSW 2000 Australia
  • Phone: +61 2 9375 0100
  • Email: Contact Us
Advent Health Limited

Advent Health Limited

About Advent Heath

Advent Health has consolidated a group of allied health practices in a highly fragmented industry into a sustainable business that maintains and enhances profitability and clinical outcomes through answering the “why” as well as the “how”. The group will provide support to individual practices to allow them to focus on their patients while being able to retain their individual branding.

Highlights

  • ‘AH1’ ticker secured from the ASX
  • 15 businesses under binding agreement with $11m+ of EBITDA and $60m of Revenue
  • Average purchase price of 5x EBITDA – in line with market multiples for these businesses
  • Average portion of purchase price taken by vendor as shares is 35%
  • Vendor shares are subject to 24 months voluntary escrow with clawback provisions
  • Management have extensive experience in the industry
  • Strong pipeline of potential future acquisitions
  • Allied Health market is still highly fragmented with low levels of corporatisation
  • Competitive pricing on IPO to existing ASX listed entities
  • Targeted listing in October 2019

Pre-IPO funds to raise (s708 Sophisticated Investors Only) - Offer Closed

Terms: Advent is looking to raise up to $2M in the form of Convertible Notes in preparation for its IPO scheduled for October 2019.

Conversion Price: 50% of IPO price with attaching Options, with 5% p.a. coupon paid bi-annually.

For further information, please contact Gavan Farley of Novus Capital Limited on 02 9375 0114 or via email gavan.farley@novuscapital.com.au